Skip to content
Quantum Biopharma logo

Quantum Biopharma (QNTM) Q2 2024 Earnings

QNTM·Reported May 14, 2024·Before market open

Diluted EPS came in at $-3.25.

Diluted EPS
$-3.25met estimate
Consensus: $-3.25
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet

Filings will appear here once submitted to SEC EDGAR.

Q2 2024 Earnings FAQ

Common questions about Quantum Biopharma's Q2 2024 earnings report.

Quantum Biopharma (QNTM) reported Q2 2024 earnings on May 14, 2024 before market open.

Quantum Biopharma reported diluted EPS of $-3.25 for Q2 2024.

EPS beat the consensus estimate of $-3.25 by $0.00.